EXTON, Pa., Oct. 22 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY) will present at the Sidoti New York Emerging Growth Institutional Investor Conference II at The Grand Hyatt in New York on Tuesday, October 28, 2008.

Joseph W. Kaufmann, Kensey Nash's President & CEO, will deliver the Company's presentation, beginning at approximately 1:30 p.m. (ET). The presentation materials will be available on the company's website (http://www.kenseynash.com) beginning at 1:30 p.m. (ET) on Tuesday, October 28, 2008 and will remain on the website for approximately two weeks.

About Kensey Nash Corporation. Kensey Nash Corporation is a leading medical technology company providing innovative solutions and technologies for a wide range of medical procedures. The Company provides an extensive range of products into multiple medical markets, primarily sports medicine, spine, and endovascular markets. Many of the products are based on the Company's significant expertise in the design, development, manufacturing and processing of absorbable biomaterials, which has led to partnerships to commercialize technologies. Kensey Nash has also developed and commercialized a series of innovative endovascular products and recently completed the sale of this product line to Spectranetics Corporation. In conjunction with the sale transaction, the Company will continue to manufacture and develop these products for Spectranetics for a period of time. The Company is known as a pioneer in the field of arterial puncture closure, as the inventor and developer of the Angio-Seal(TM) Vascular Closure Device, which is licensed to St. Jude Medical, Inc.

SOURCE Kensey Nash Corporation